(249 days)
Not Found
No
The device description and performance studies focus on physical characteristics and standard biocompatibility/mechanical testing, with no mention of AI/ML terms, image processing, or data-driven performance metrics.
No
The device is used for introducing and placing guidewires and/or catheters into the vascular system, primarily as an access tool, not for treating a disease or condition itself.
No
The device is described as assisting in gaining vascular access for the placement of guidewires and catheters, which is a procedural function, not a diagnostic one.
No
The device description explicitly lists physical components such as needles, sheaths, dilators, and guidewires, indicating it is a hardware medical device, not software-only.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is "in the introduction and placement of guidewires and/or catheters" into the vascular system. This is a procedural device used in vivo (within the body) for accessing blood vessels.
- Device Description: The components (needles, introducers, guidewires) are all tools for accessing and navigating the vascular system.
- Lack of IVD Characteristics: There is no mention of the device being used to examine specimens derived from the human body (like blood, urine, tissue) to provide information for diagnosis, monitoring, or screening.
IVD devices are used to perform tests outside the body on biological samples. This device is used inside the body to facilitate medical procedures.
N/A
Intended Use / Indications for Use
The V•Stick™ Vascular Access Sets intended for use in the introduction and placement of guidewires and/or catheters
Product codes (comma separated list FDA assigned to the subject device)
DYB
Device Description
The V•Stick™ Vascular Access Set assists in gaining vascular access for the placement of 0.035" and 0.038" guidewires into the vascular system using small needle access. It is composed of a 21ga puncture needle with and without silicone coating, and available with or without an echogenic tip. A coaxial introducer set with a 4F or 5F sheath and a standard or stiff 3F dilator is included. Finally a 0.018" stainless steel or Nitinol guidewire with a platinum or palladium alloy coil tip.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The device design has been qualified through the following tests:
- Dimensional Verification
- Visual Inspection
- Weld Strength
- Radiopacity
- Sensitization
- Ultrasound Visibility
- Sharpness
- Stiffness Comparison
- Tensile Strength
Biocompatibility testing per ISO 10993-1 was performed, consisting of the following tests: - Cytotoxicity
- Acute systemic toxicity
- Hemocompatibility
- Irritation/intracutaneous reactivity
The results of this testing demonstrates that the V.StickTM Vascular Access Set, is substantially equivalent to the predicate devices and did not raise new safety or performance questions.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.1340 Catheter introducer.
(a)
Identification. A catheter introducer is a sheath used to facilitate placing a catheter through the skin into a vein or artery.(b)
Classification. Class II (performance standards).
0
NOV 2 2 2013
K130730
pg 1/3
510(k) Summary
| Date Prepared: | March 27, 2013 |
|---|---|
| Company: | Argon Medical |
| 3600 SW 47th Ave. | |
| Gainesville, FL 32608 | |
| Facility Registration number: 1037610 | |
| Contact: | Jennifer Bonacci |
| Regulatory Affairs Manager | |
| Phone: 352-519-5029 | |
| Fax: 352-338-0662 | |
| Email: jennifer.bonacci@argonmedical.com | |
| Sterilization Site | STERIS Isomedix Services, Inc. |
| 2072 Southport Road | |
| Spartanburg, SC 29306-6299, USA | |
| Facility Registration number: 1047843 | |
| Device trade name: | V•Stick™ Vascular Access Set |
| Device Common | |
| Name: | Vascular access set |
| Device classification: | Introducer, catheter |
| Product code, DYB | |
| 21 CFR 870.1340 | |
| Class II | |
| Legally marketed | |
| device to which the | |
| device is substantially | |
| equivalent: | K011790 MicroCruiser® Plus Introducer Set |
| K091584 Merit MAK (Mini Access Kit) | |
| K851834 Manan GWI Guidewire Introducer | |
| Description of the | |
| device: | The V•Stick™ Vascular Access Set assists in gaining vascular |
| access for the placement of 0.035" and 0.038" guidewires into the | |
| vascular system using small needle access. It is composed of a | |
| 21ga puncture needle with and without silicone coating, and | |
| available with or without an echogenic tip. A coaxial introducer | |
| set with a 4F or 5F sheath and a standard or stiff 3F dilator is | |
| included. Finally a 0.018" stainless steel or Nitinol guidewire | |
| with a platinum or palladium alloy coil tip. | |
| Indications for Use: | The V•Stick™ Vascular Access Sets intended for use in the |
| introduction and placement of guidewires and/or catheters |
1
Technological The subject of this 510(k) is to provide an additional offering for Characteristics: the current V.Stick Vascular Access Set to include a 0.018" guidewire with a palladium/rhenium coil tip and a silicone coated . 21 ga puncture needle in addition to the existing co-axial introducer set.
The V.Stick Vascular Access Set is similar in design components. dimensions, and materials to the predicate devices. The MicroCruiser® [K011790], Merit MAK [K091584], and V.Stick are all available in the same French and 0.018" guidewire sizes. The lengths of the co-axial introducer, guidewire and puncture needle are identical. The materials found in all three sets are similar. The spring tip of the 0.018" guidewire is made of radiopaque material as is the guidewire tip in the predicate set.
The distal tip of the 21ga puncture needle may or may not have echogenic properties which are also true in the predicate sets. This needle is also provided with a silicone coating just as the predicate Manan Guidewire Introducer Needle [K851834].
The V.Stick Vascular Access Set, like the predicate devices, is compatible with guidewires with a maximum outer diameter of 0.038". All three access sets are sterilized in an ethylene oxide process and have similar sterile barrier packaging materials.
The V.Stick Vascular Access Set has the same indications for use, technical characteristics, and materials as the MicroCruiser® Plus Introducer. The V.Stick Vascular Access Set has the same introducer needle with silicone coating as the Manan GWI Guide Wire Introducer and the same intended use. The V.StickTM Vascular Access Set has the same 0.018" guidewire with palladium alloy coil tip as the Merit MAK® Mini Access Kit and the same intended use.
Substantial Equivalence:
2
Performance tests (Non-Clinical):
The V.Stick Vascular Access Set is substantially equivalent to the specified predicate devices based on comparisons of the device functionality, technological characteristics, and Indications for Use. The device design has been qualified through the following tests:
- o Dimensional Verification . Visual Inspection
- . Weld Strength
- Radiopacity .
Sensitization
.
.
.
- Ultrasound Visibility .
- Sharpness
Stiffness Comparison
-
Tensile Strength .
Biocompatibility testing per ISO 10993-1 was performed, consisting of the following tests: -
. Cytotoxicity .
- Acute systemic toxicity Hemocompatibility .
-
Irritation/intracutaneous reactivity .
The results of this testing demonstrates that the V.StickTM Vascular Access Set, is substantially equivalent to the predicate devices and did not raise new safety or performance questions.
3
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle or bird-like symbol with three curved lines representing its wings or body. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the symbol. The logo is presented in black and white.
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-002
November 22, 2013
Argon Medical C/O Jennifer Bonacci Regulatory Affairs Manager 3600 Southwest 47th Avenue Gainesville, FL 32608 US
Re: K130730
Trade/Device Name: V-Stick™ Vascular Access Set Regulation Number: 21 CFR 870.1340 Regulation Name: Catheter Introducer Regulatory Class: Class II Product Code: DYB Dated: October 17, 2013 Received: October 23, 2013
Dear Ms. Bonacci:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally murketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or 10 devices that have been reclassified in accordance with the provisions of the Federal Food, Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not mislcading.
If your device is classified (sec above) into cither class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
4
Page 2 - Ms. Jennifer Bonacci
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely vours.
M. A. Hillerman
for Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
Indications for Use
Form Approved: OMB No. 0910-0120 Expiration Date: December 31, 2013 See PRA Statement on last page.
510(k) Number (if known) K130730
Device Name V.Stick™ Vascular Access Set
Indications for Use (Describe)
V.Stick™ Vascular Access Sets intended for use in the introduction and placement of guidewires and/or catheters
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
・・
PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON A SEPARATE PAGE IF NEEDED.
FOR FDA USE ONLY
Concurrence of Center for Devices and Radiological Health (CDRH) (Signature)
M. L. Hillemann
FORM FDA 3881 (9/13)
PSC Publishim Services (301) 443-474) EP